Last reviewed · How we verify

NCT05252832

Superficial Cervical Plexus Block for IJCL Pain Management

Completed NA Last updated 4 May 2025
What this trial tests

NA trial testing Superficial Cervical Plexus Block in Superficial Cervical Plexus Block in 14 participants. Completed in 31 December 2024.

Timeline
15 January 2022
Primary endpoint
20 January 2024
31 December 2024

Quick facts

Lead sponsorCleveland Clinic Akron General
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment14
Start date15 January 2022
Primary completion20 January 2024
Estimated completion31 December 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Cleveland Clinic Akron General

Who can join

18 and older, any sex, with Superficial Cervical Plexus Block or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective randomized trial evaluating the effect of SCPB on reported patient pain following IJCL placement as compared to local infiltrate.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Superficial Cervical Plexus Block

Currently open trials in the same condition.

Other Cleveland Clinic Akron General trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05252832.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing